New Research Poster Presentation 3.20: Clinical Response and Symptomatic Remission in Children Treated with Lisdexamfetamine Dimesylate for ADHD

Thursday, October 29, 2009 12:30 PM

James J. McGough, M.D., University of California at Los Angeles Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA

Ben Adeyi, M.S., Shire Pharmaceuticals Inc., Wayne, PA

Gary Chen, Ph.D., Shire Pharmaceuticals Inc., Wayne, PA

Bryan Dirks, M.D., Shire Pharmaceuticals Inc., Wayne, PA

Thomas Babcock, D.O., Ph.D., Shire Pharmaceuticals Inc., Wayne, PA

Brian Scheckner, PharmD, Shire Pharmaceuticals Inc., Wayne, PA

Robert Lasser, M.D., Shire Pharmaceuticals Inc., Wayne, PA

Robert L. Findling, M.D., University Hospitals Case Medical Center, Cleveland, OH

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 3.20 Clinical Response and Symptomatic Remission in Children Treated with Lisdexamfetamine Dimesylate for ADHD